| Date Filed | Type | Description |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 48,000 options to buy
@ $1.26, valued at
$60.5k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 50,000 restricted stock units
@ $0 |
|
| 09/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2020 |
4
| Basta Steven L (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $1.72, valued at
$38.7k
|
|
| 04/07/2020 |
4
| Basta Steven L (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 14,499 shares
@ $0 |
|
| 03/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Basta Steven L (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 7,108 shares
@ $0 |
|
| 12/16/2019 |
4/A
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 85,210 shares
@ $4.52, valued at
$385.1k
Exercised 238,800 restricted stock units
@ $0
Exercised 14,000 options to buy
@ $1.83, valued at
$25.6k
|
|
| 12/13/2019 |
4
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 85,210 shares
@ $4.52, valued at
$385.1k
Exercised 238,800 restricted stock units
@ $0
Exercised 14,000 options to buy
@ $1.83, valued at
$25.6k
|
|
| 11/27/2019 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 660,000 options to buy
@ $0.869, valued at
$573.5k
|
|
| 08/07/2019 |
4/A
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 238,800 restricted stock units
@ $0 |
|
| 07/31/2019 |
4
| Basta Steven L (See Remarks) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 238,800 restricted stock units
@ $0 |
|
| 05/31/2019 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 35,000 options to buy
@ $0.58, valued at
$20.3k
|
|
| 04/03/2019 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 24,199 shares
@ $0 |
|
| 01/16/2019 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 35,000 options to buy
@ $1.24, valued at
$43.4k
|
|
| 12/12/2018 |
4
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 141,900 options
@ $5.51, valued at
$781.9k
|
|
| 09/14/2018 |
4
| Basta Steven L (Director) has filed a Form 4 on VIVEVE MEDICAL, INC.|
Txns:
| Granted 70,000 options to buy
@ $3.45, valued at
$241.5k
|
|
| 09/13/2018 |
3
| Basta Steven L (Director) has filed a Form 3 on VIVEVE MEDICAL, INC. |
| 05/04/2018 |
4
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 212,850 options
@ $8.49, valued at
$1.8M
|
|
| 01/24/2018 |
3
| Basta Steven L (CEO) has filed a Form 3 on Menlo Therapeutics, Inc. |
| 11/22/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/05/2015 |
4
| Basta Steven L (Director) has filed a Form 4 on Carbylan Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $6.91, valued at
$108.8k
|
|
| 02/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/06/2009 |
4
| Basta Steven L (CEO) has filed a Form 4 on BIOFORM MEDICAL INC |
| 04/09/2009 |
4
| Basta Steven L (CEO) has filed a Form 4 on BIOFORM MEDICAL INC |
| 01/26/2009 |
4
| Basta Steven L (CEO) has filed a Form 4 on BIOFORM MEDICAL INC |